Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma

Pamela B. Allen^*, Xinyan Lu, Qing Chen, Kaitlyn O’Shea, Joan S. Chmiel, Liron Barnea Slonim, Madina Sukhanova, Hatice Savas, Andrew M. Evens, Ranjana Advani, Barbara Pro, Reem Karmali, Brett Palmer, Robert A. Bayer, Robert M. Eisner, Eric Mou, Gary Dillehay, Leo I. Gordon, Jane N. Winter